Study guide
11.3 Pulmonic Stenosis Assessment
CCI Registered Cardiac Sonographer RCS
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: RCS Orientation and Clinical Context
1.1 RCS Identity, Exam Format, Application, and Retesting 1.2 Clinical History, Symptoms, Indications, and Risk Factors 1.3 Prior Studies, Serial Change, and Cross-Modality Context
2 Chapter 2: Orders, Safety, and Patient Preparation
2.1 Order Verification, Scope, and Protocol Selection 2.2 Sonographer Ergonomics and Staff Safety 2.3 Patient Preparation, Positioning, Consent, Infection Control, and Aftercare
3 Chapter 3: Reporting and 2-D TTE Foundations
3.1 Structured Findings, Significant Results, and Escalation 3.2 Standard 2-D TTE Windows, Views, and Acquisition Sequence 3.3 2-D Measurements, Foreshortening, Image Quality, and QA
4 Chapter 4: M-Mode and Doppler Acquisition
4.1 M-Mode Alignment, Timing, Measurements, and Pitfalls 4.2 Color Doppler Acquisition, Scale, Gain, and Jet Display 4.3 PW and CW Spectral Doppler Acquisition
5 Chapter 5: Advanced Doppler and Contrast
5.1 Tissue Doppler and Hemodynamic Sample Placement 5.2 Ultrasound-Enhancing Agents and LV Opacification 5.3 Agitated-Saline Studies and Intracardiac Shunts
6 Chapter 6: Stress Echocardiography
6.1 Exercise Stress Echo Protocols and Peak Imaging 6.2 Pharmacologic Stress Echo, Dobutamine, and Safety 6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation
7 Chapter 7: TEE, Strain, and 3-D TEE
7.1 Assisting TEE: Preparation, Probe Safety, Views, and Complications 7.2 Strain Acquisition, Tracking Quality, and Reproducibility 7.3 3-D TEE Acquisition, Cropping, Orientation, and Artifacts
8 Chapter 8: 3-D TTE and the Aortic Valve
8.1 3-D TTE Full-Volume Acquisition and Quantitation 8.2 Aortic-Valve Anatomy, Morphology, and Function 8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States
9 Chapter 9: Aortic Regurgitation and Mitral Structure
9.1 Aortic Regurgitation Mechanisms and Integrated Severity 9.2 Mitral-Valve Anatomy, Motion, and Mechanisms 9.3 Mitral Stenosis: Planimetry, Gradients, Pressure Half-Time, and Suitability
10 Chapter 10: Mitral and Tricuspid Valve Findings
10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration 10.2 Tricuspid-Valve Anatomy, Structure, and Function 10.3 Tricuspid Stenosis Assessment
11 Chapter 11: Right-Sided Valve Disease
11.1 Tricuspid Regurgitation Mechanism and Severity 11.2 Pulmonic-Valve Anatomy, Structure, and Function 11.3 Pulmonic Stenosis Assessment
12 Chapter 12: Pulmonic Regurgitation and Prosthetic Valves
12.1 Pulmonic Regurgitation Mechanism and Severity 12.2 Normal Mechanical and Bioprosthetic Valve Assessment 12.3 Prosthetic Obstruction, Regurgitation, Thrombosis, and Patient–Prosthesis Mismatch
13 Chapter 13: Endocarditis and Cardiac Chambers
13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications 13.2 LV and LA Size, Geometry, Volumes, Mass, and Function 13.3 RV and RA Size, Pressure, Volume, and Function
14 Chapter 14: Cardiomyopathy Phenotypes and Diastology
14.1 Dilated and Hypertrophic Cardiomyopathies, SAM, and LVOT Obstruction 14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies 14.3 Diastolic Function, Filling Pressure, Grading, and Pitfalls
15 Chapter 15: Systolic Function and Ischemia
15.1 LV Systolic Function, Simpson EF, Regional Motion, and Output 15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling 15.3 Ischemic Heart Disease, Coronary Territories, Stress Response, and Complications
16 Chapter 16: Pericardium and Great Vessels
16.1 Pericardial Effusion, Tamponade, Constriction, and Doppler Physiology 16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment 16.3 Aortic Root, Aneurysm, Dissection, and Coarctation
17 Chapter 17: Pulmonary Pressure, Masses, and Congenital Recognition
17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences 17.2 Cardiac Masses, Thrombus, Tumor, Vegetation, and Mimics 17.3 Adult Recognition of ASD, VSD, PFO, PDA, and Congenital Clues
18 Chapter 18: Devices, Strain, and Hemodynamics
18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support 18.2 Strain Interpretation, Global Longitudinal Strain, and Disease Patterns 18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts
19 Chapter 19: Infiltrative Disease and Physics Foundations
19.1 Amyloid, Sarcoid, and Other Infiltrative Disease Patterns 19.2 Ultrasound Wave Properties, Propagation, Frequency, and Wavelength 19.3 Artifact Recognition: Reverberation, Shadowing, Mirror, Refraction, and Aliasing
20 Chapter 20: Resolution and Doppler Optimization
20.1 Axial/Lateral Resolution, Frame Rate, Depth, Focus, and Trade-Offs 20.2 Spectral Doppler Optimization, Nyquist, Filters, Gain, and Angle 20.3 Color Doppler Optimization, Scale, Priority, Variance, and Gain
21 Chapter 21: 2-D, 3-D, and Contrast Optimization
21.1 2-D Optimization: Frequency, Gain, TGC, Harmonics, Depth, and Focus 21.2 3-D Optimization: Volume Rate, Stitching, Cropping, and Display 21.3 Contrast Optimization: Mechanical Index, Destruction, Replenishment, and Artifacts
11.3 Pulmonic Stenosis Assessment
Key Takeaways Explain This Topic AI
Prove valvular PS by showing cusp abnormality and localizing the first velocity increase at the annulus; CW velocity alone cannot distinguish adjacent obstruction.
Peak Doppler gradient is 4V² and is a maximum instantaneous gradient, not a catheter peak-to-peak measurement; include proximal velocity when it is not negligible.
Conventional mild, moderate, and severe velocity bands require integration with flow state, respiration, rhythm, RV hypertrophy and function, and associated lesions.
TR-derived RVSP does not equal PASP in PS because the obstruction creates an RV-to-pulmonary-artery pressure drop.
Last updated: July 2026
Prove that the obstruction is valvular
Pulmonic stenosis, or PS, usually reflects congenital commissural fusion producing a doming valve with a narrow systolic opening. Dysplastic cusps may be thick and poorly mobile without doming. Less common acquired causes include rheumatic disease, carcinoid, or prior intervention. A high velocity near the pulmonic valve is not sufficient: subvalvular muscle bundles, dynamic RVOT narrowing, supravalvular MPA stenosis, branch stenosis, a conduit, or high flow can produce a similar CW signal.
Use 2-D sweeps from parasternal short-axis, PA-focused, subcostal, and modified apical windows. Record cusp number when genuinely seen, thickness, systolic mobility and doming, annular size, RVOT anatomy, MPA and branch caliber, and poststenotic dilation. Color should show the narrowest origin of the systolic jet. Step PW from proximal RVOT through the annulus and into the MPA; the first velocity increase localizes the obstruction. If PW aliases, move the gate proximally and distally rather than guessing from the mosaic.
Align spectral Doppler and calculate correctly
Use CW through the localized jet from every window that approaches parallel flow. Save the highest reproducible, complete envelope without angle correction. Trace the dense modal edge for peak velocity and mean gradient. The simplified Bernoulli equation converts peak velocity to maximum instantaneous pressure difference:
Peak gradient = 4V²
A velocity of 3.5 m/s gives 4 × 3.5² = 49 mm Hg. This Doppler maximum instantaneous gradient is not the same as the catheter peak-to-peak gradient, which compares nonsimultaneous chamber peaks and is usually lower. Name the Doppler quantity correctly. The machine-derived mean gradient averages instantaneous gradients across systole; it cannot be calculated by inserting mean velocity into 4V².
When proximal RVOT velocity is not negligible, use the expanded relation 4(V₂² − V₁²) rather than assuming V₁ is zero. This matters with serial obstruction, a tunnel, high flow, or substantial subvalvular acceleration. Match proximal and distal signals from representative beats. Do not add Doppler gradients from separate levels; pressure differences are not simple independent numbers when velocities and recovery interact.
Acquisition step Valid evidence Frequent error
2-D and color Doming or dysplastic cusps and jet origin at annulus Calling valvular PS when cusps are not resolved
Sequential PW First step-up localizes level and provides proximal V₁ Placing PW only in the poststenotic jet and losing range validity to aliasing
Multiwindow CW Highest complete velocity parallel to the localized jet Using the prettiest lower velocity or angle correcting a misaligned signal
CW tracing Peak instantaneous and true traced mean gradient Calling Doppler peak the catheter peak-to-peak gradient
Respiratory/rhythm capture Reproducible beats over quiet respiration Measuring one inspired, postectopic, or incomplete envelope
Use velocity bands as one part of severity
ASE valve-stenosis guidance uses these conventional Doppler bands for valvular PS:
- Band Peak velocity Calculated peak instantaneous gradient
- Mild <3.0 m/s <36 mm Hg
- Moderate 3.0–4.0 m/s 36–64 mm Hg
- Severe >4.0 m/s >64 mm Hg
The category assumes a correctly localized, well-aligned jet and an interpretable flow state. High cardiac output from anemia, pregnancy, fever, or shunt can elevate velocity without a smaller anatomic orifice. Low output, severe RV dysfunction, or critical obstruction can yield a lower-than-expected gradient. Tachycardia, arrhythmia, respiration, and positive-pressure ventilation change right-sided filling and ejection. Record heart rate, rhythm, oxygen and ventilation conditions, and relevant loading; average protocol-defined beats in irregular rhythm. No single cutoff should overrule clearly discordant cusp anatomy or RV response.
Integrate the right-heart consequences
Chronic pressure overload produces RV hypertrophy, then possible dilation and systolic or diastolic dysfunction. Assess RV wall thickness, size, FAC, TAPSE, tissue Doppler s′, strain when available, RA size, IVC and systemic venous congestion, septal configuration, and secondary TR. Poststenotic MPA dilation supports a valvular high-velocity jet but is not a severity grade. Atrial shunting may decompress the right heart and alter flow; inspect the septum when RA pressure is high. Symptoms, exercise response, and serial change are interpreted by the physician with the anatomic and Doppler record.
Use the TR signal carefully. RV systolic pressure equals 4(TR velocity)² plus estimated RA pressure when the signal is valid. With no RVOT or pulmonic obstruction, RVSP can approximate pulmonary artery systolic pressure. In PS, however, the valve gradient separates RV and PA pressures, so RVSP must not be mislabeled PASP. A rough PA systolic estimate may subtract the obstruction gradient from RVSP only when measurements are compatible and no additional obstruction exists; severe TR, poor envelopes, branch disease, and different beats can invalidate that arithmetic.
A low TR velocity does not prove low RV pressure if the beam is misaligned or the jet is incomplete. Conversely, a high RVSP in severe PS describes RV pressure load, not pulmonary hypertension. Cross-check septal flattening, RV hypertrophy, PA flow, PR-derived pressures when valid, and the overall pulmonary-hemodynamic pattern. Right-heart catheterization or cross-sectional imaging may be needed when noninvasive data are discordant and management depends on exact pressures or anatomy.
Distinguish residual disease and associated lesions
After balloon valvuloplasty or surgery, document residual jet level and gradient, cusp or prosthetic motion, PR, annular and MPA anatomy, RV remodeling, and branch obstruction. A lower gradient with worsening PR may reflect a trade-off rather than complete normalization. In a conduit or prosthetic valve, apply the device-specific baseline and prosthetic guidance rather than native-valve cutoffs alone.
Before finalizing, verify that the highest CW signal corresponds to the lesion localized by PW and color, all measured envelopes are complete, proximal velocity was considered, and respiration and rhythm are documented. Reconcile Doppler category with cusp motion, poststenotic change, RV pressure load, function, and flow state. The RCS sonographer supplies a technically defensible integrated dataset; intervention decisions require clinical and multidisciplinary assessment.
RVSP is not PASP when PS is present
Pulmonic or RVOT obstruction creates a systolic pressure drop between RV and pulmonary artery. A valid TR-derived RVSP therefore describes RV pressure load and cannot be labeled pulmonary artery systolic pressure without accounting for the obstruction.